Lemborexant
Lemborexant is a pharmaceutical drug with 23 clinical trials. Currently 6 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
3
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
15 of 15 finished
0.0%
0 ended early
6
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems
Lemborexant in Delayed Sleep Phase Syndrome
Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients
Lemborexant Shift Work Treatment Study
Clinical Trials (23)
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems
Lemborexant in Delayed Sleep Phase Syndrome
Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients
Lemborexant Shift Work Treatment Study
A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder
Lemborexant in Delayed Sleep Phase Syndrome
Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia
Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)
Lemborexant Treatment of Insomnia Linked to Epilepsy
Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients
A Study of Lemborexant in Chinese Participants With Insomnia Disorder
Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)
Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers
A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.
A Study to Evaluate Lemborexant in Milk of Healthy Lactating Women
A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants
Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects
Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 23